Bad news re: ICD-10, certification and privacy

This week in health IT had some bad news on just about every front.

For starters, more than half of healthcare organizations are not yet ready for the Oct. 1 ICD-10 transition. A survey conducted by Porter Research and commissioned by Navicure found that 85 percent of respondents expect to be ready for the transition by Oct. 1 but 57 percent are not currently ready.

More than one-third (35 percent) of respondents had not yet conducted any end-to-end testing and, among those who had completed end-to-end testing, 60 percent reported positive results.

Meanwhile, the Office of the National Coordinator for Health IT terminated the certification of two EHR products that were being used to meet the requirements of the EHR Incentive Programs, saying the products no longer meet ONC Health IT Certification Program requirements.

After failing to respond to and participate in routine surveillance requests by an ONC-authorized certification body, two versions of Platinum Health Information System's SkyCare 4.2 EHR lost their certifications.

On the privacy and security front, an Indianapolis oncology practice faces a $750,000 HIPAA settlement from the Department of Health and Human Services for failing to encrypt devices and laptops containing patient data. The practice agreed to pay the sum to settle alleged HIPAA violations involving a breach that occurred three years ago.

Cancer Care Group had an unencrypted server backup media and laptop stolen from an employee's car in 2012, which affected about 55,000 patients.

The Office for Civil Rights clearly is serious about risk assessments and strong policies and procedures related to the protection of patient data. Is your organization meeting those standards?

Beth Walsh

Clinical Innovation + Technology editor

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup